Company
InterCure Ltd
Headquarters: Herzliya, Israel
Employees: 75
CEO: Mr. Alexander Rabinovich
Market Cap
₪252.5 Million
ILS as of Jan. 1, 2024
US$69.9 Million
InterCure Ltd Categories
Israel Healthcare Drug Manufacturers—Specialty & GenericIsrael Healthcare Israel Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
InterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
InterCure Ltd has the following listings and related stock indices.
Stock: TASE: INCR wb_incandescent
Stock: OTC: IRCLF wb_incandescent
Stock: NASDAQ: INCR wb_incandescent
Stock: TSX: INCR.U wb_incandescent